Longitude (Cayman) Ltd. Amarin Corp Plcuk Transaction History
Longitude (Cayman) Ltd.
- $69.8 Million
- Q4 2024
A detailed history of Longitude (Cayman) Ltd. transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Longitude (Cayman) Ltd. holds 1,620,000 shares of AMRN stock, worth $24.3 Million. This represents 1.11% of its overall portfolio holdings.
Number of Shares
1,620,000
Previous 2,370,000
31.65%
Holding current value
$24.3 Million
Previous $1.49 Million
47.96%
% of portfolio
1.11%
Previous 2.49%
Shares
17 transactions
Others Institutions Holding AMRN
# of Institutions
102Shares Held
59.6MCall Options Held
133KPut Options Held
26.4K-
Sarissa Capital Management LP Greenwich, CT24.9MShares$373 Million60.8% of portfolio
-
Kynam Capital Management, LP Princeton, NJ12.4MShares$186 Million9.37% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$51 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$39.3 Million0.0% of portfolio
-
Scp Investment, LP2.5MShares$37.5 Million17.88% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $6.04B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...